Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Pasadena, CA
SEC filing record 1 source field available
Fiscal year end
30 September
ARROWHEAD PHARMACEUTICALS, INC. has filed 1,338 SEC EDGAR filings since 02 Jan 1998

SEC filing history

Showing 301-325 of 995 matching filings.

Per page
25
Current page
13
4

FORM 4 SUBMISSION

Filing date
22 Nov 2022
Reporting date
21 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
5

FORM 5 SUBMISSION

Filing date
30 Sep 2022
Reporting date
30 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Sep 2022
Reporting date
27 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
12 Jul 2022
Reporting date
08 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
11 Jul 2022
Reporting date
07 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
29 Jun 2022
Reporting date
20 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
05 May 2022
Reporting date
02 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-38042

DEFA14A

Filing date
09 Mar 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Feb 2022
Reporting date
11 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-48710

SCHEDULE 13G/A

Filing date
09 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-48710

SC 13G/A filing

Filing date
27 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-38042

DEF 14A

Filing date
26 Jan 2022
Reporting date
17 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .